← Back to Search

Lifestyle Management Program for Obesity(CHAMPS Trial)

N/A

Recruiting

Led By Karen Johnson, MD

Research Sponsored by University of Tennessee

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

are overweight or obese (BMI ≥ 25 kg/m2)

Must not have

Timeline

Screening 3 weeks

Treatment Varies

Follow Up12 months

Awards & highlights

No Placebo-Only Group

CHAMPS Trial Summary

This trial will test whether a weight loss intervention delivered through health IT tools can help people lose more weight than a diabetes support and education intervention.

Eligible Conditions

Overweight and Obesity
Weight Loss
Health Behaviors

CHAMPS Trial Eligibility Criteria

Inclusion Criteria

You will be eligible if you check “Yes” for the criteria below

Select...

You have a body mass index (BMI) greater than or equal to 25, which means you are overweight or obese.

CHAMPS Trial Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ 12 months

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~12 months

This trial's timeline: 3 weeks for screening, Varies for treatment, and 12 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Relative percentage change in weight

Secondary outcome measures

Relationship of social determinants of health (BRFSS) with weight change over time

Relationship of social determinants of health (screening tool) with weight change over time

Relationship of social determinants of health (z codes) with weight change over time

Awards & Highlights

No Placebo-Only Group

All patients enrolled in this study will receive some form of active treatment.

CHAMPS Trial Design

2Treatment groups

Experimental Treatment

Active Control

Group I: Active Intervention GroupExperimental Treatment1 Intervention

Look AHEAD Intervention program adapted for delivery via Health IT modified for cultural and social norms applicable to under-served population groups

Group II: Comparison GroupActive Control1 Intervention

Look AHEAD DSE (Diabetes Support and Education) Comparison Group intervention adapted to be delivered via the EHR patient portal with telephonic support

0 / 1Eligibility criteria met

Find a Location

Who is running the clinical trial?

National Cancer Institute (NCI)NIH

13,490 Previous Clinical Trials

41,266,465 Total Patients Enrolled

45 Trials studying Obesity

21,989 Patients Enrolled for Obesity

Regional One HealthOTHER

4 Previous Clinical Trials

743 Total Patients Enrolled

University of TennesseeLead Sponsor

188 Previous Clinical Trials

141,827 Total Patients Enrolled

19 Trials studying Obesity

3,433 Patients Enrolled for Obesity

Media Library

Active Intervention Group Clinical Trial Eligibility Overview. Trial Name: NCT05410353 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is enrollment for this research initiative still open to participants?

"Confirmed, this study is not enrolling patients. The trial was initially advertised on January 1st 2023 and its status last changed on June 8th 2022. Nevertheless, there are currently 1293 other clinical trials with open enrollment requirements."

Answered by AI